Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Thymus Neoplasms × Proton Therapy × Clear all

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Meningioma 3 Brain Neoplasms 3 Sarcoma 2 Radiation Injuries 2 Pituitary Neoplasms 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Esophageal Neoplasms 2 Wilms Tumor 1 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Resectable Lung Non-Small Cell Carcinoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neurilemmoma 1 Neoplasms, Adipose Tissue 1 Nasopharyngeal Carcinoma 1 Myoepithelioma 1 Malignant Brain Glioma 1 Liposarcoma, Myxoid 1

Interventions

fludarabine 1 Tumor Burden 1 Quality of Life 1 Proton Therapy 1 Immunotherapy 1 Histocompatibility Testing 1 Everolimus 1 Drug Therapy 1 Cyclophosphamide 1 Blood Specimen Collection 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡